Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Verifiedinfo

Centrum Gastroenterologie Bethanien

Germany Im Prüfling 21-25, 60389 Frankfurt, Germany

  • 2 trials recruiting
  • Irritable bowel syndrome · Functional gastrointestinal disorder
  • Adult patients

About Specializations

Centrum Gastroenterologie Bethanien in Frankfurt, Germany specialises in clinical trials of conditions such as Irritable bowel syndrome, Functional gastrointestinal disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

The research conducted at Centrum Gastroenterologie Bethanien addresses functional gastrointestinal disorders. It focuses on diarrhoea‑dominant irritable bowel syndrome and its mixed‑type variant.

  • Evaluation of symptom reduction in IBS‑D patients
  • Safety and tolerability profiling of a novel oral formulation
  • Placebo‑controlled comparison of therapeutic outcomes
  • Investigation of efficacy in mixed‑type irritable bowel syndrome (IBS‑M)

The objective is to demonstrate that MYRRHINIL‑INTEST® can safely alleviate bowel distress and enhance daily functioning for individuals with these chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Im Prüfling 21-2560389 FrankfurtGermany
Open in maps ↗
Recruiting now
2 trials
Conditions studied
2
Partner status
Verified

More sites in FrankfurtGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Irritable bowel syndrome

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Coffee Charcoal
  • Sponsor:REPHA GmbH Biologische Arzneimittel

Irritable bowel syndrome

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Coffee Charcoal
  • Sponsor:REPHA GmbH Biologische Arzneimittel

Functional gastrointestinal disorder

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Caraway Oil
  • Sponsor:Dr. Willmar Schwabe GmbH & Co. KG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).